Company: CERO
Filing Date: 2025-04-25
Form Type: PRE 14A
Source: 0001213900-25-035562
Chunk: 24

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-04-25
Form: PRE 14A
Chunk 24
---
 practices pertain to the payment of brokers’ commissions and to time -consumingprocedures that function to make the handling of low -pricedstocks unattractive to brokers from an economic standpoint. In addition, the structure of trading commissions also tends to have an adverse impact upon holders of low -pricedstock because the brokerage commission on a sale of low -pricedstock generally represents a higher percentage of the sales price than the commission on a relatively higher -pricedissue. In order to provide flexibility, the Board is seeking stockholder approval for a range of reverse split ratios of not less than one -for- and not more than one -for- . The need for the range is due to the volatility of our stock price, which ranged from a high of $5.85 per share to a low of $0.7300 per share between February 14, 2024 (the date of the Business Combination) and March31, 2025. We believe that enabling the Board of Directors to set the exact reverse split ratio within the stated range will provide us with the flexibility to implement the Reverse Stock Split in a manner designed to maximize the anticipated benefits for our stockholders. In determining whether to implement the Reverse Stock Split and selecting the exchange ratio, the Board of Directors will consider factors such as: •the total number of shares of Common Stock outstanding; •the Nasdaq Capital Market requirements for the continued listing of our Common Stock; •the historical trading price and trading volume of our Common Stock; •the then prevailing trading price and trading volume for our Common Stock; •the anticipated impact of the Reverse Stock Split on the trading price of and market for our Common Stock; •potential financing opportunities; and •prevailing general market and economic conditions. 10

Reducing the number of outstanding shares of our Common Stock through a Reverse Stock Split is intended, absent other factors, to increase the per share market price of our Common Stock. However, other factors, such as our financial results, market conditions and the market perception of our business may adversely affect the market price of our Common Stock. As a result, there can be no assurance that the Reverse Stock Split, if completed, will result in the intended benefits described above, that the market price of our Common Stock will increase following the Reverse Stock Split or that the market price of our Common Stock will not decrease in the future. Additionally, we cannot assure you that the market price per share of our Common Stock after a Reverse Stock Split will increase in proportion to the reduction in